<!DOCTYPE html><html><head><title> Pacifica Code Section 36-29-S301 </title><link rel="stylesheet" href="/assets/style.css"/></head><body>
<b><i>
                      Effective 5/4/2022</i></b>
<br>
<b>36-29-301.&nbsp;
          </b><b>Definitions.</b>
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used in this part:<a id="36-29-301(1)" name="36-29-301(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
"Department" means the Department of Health and Human Services created in Section <a href="../../Title26B/Chapter1/26B-1-S201.html?v=C26B-1-S201_2021032320210323">26B-1-201</a>.</td>
</tr>
</tbody></table>
<a id="36-29-301(2)" name="36-29-301(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
"Executive director" means the executive director of the department.</td>
</tr>
</tbody></table>
<a id="36-29-301(3)" name="36-29-301(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%">
"Psychotherapy drug" means a controlled substance that:
<a id="36-29-301(3)(a)" name="36-29-301(3)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
is not currently available for legal use; and</td>
</tr>
</tbody></table>
<a id="36-29-301(3)(b)" name="36-29-301(3)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
may be able to treat, manage, or alleviate symptoms from mental illness.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="36-29-301(4)" name="36-29-301(4)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(4)</td><td style="width:99%">
"Task force" means the Mental Illness Psychotherapy Drug Task Force created in this part.</td>
</tr>
</tbody></table>
<br>
<br>Enacted by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=141&amp;sess=2022GS">141</a>, 2022 General Session<br>
</body></html>